题名

Mechanism of action involved in the anxiolytic-like effects of Hibalactone isolated from Hydrocotyle umbellata L.

DOI

10.1016/j.jtcme.2021.08.012

作者

Matheus Gabriel de Oliveira；Lorrane Kelle da Silva Moreira；Larissa Cordova Turones；Dionys de Souza Almeida；Aline Nazareth Martins；Thiago Levi Silva Oliveira；Vinicius Barreto da Silva；Leonardo Luiz Borges；Elson Alves Costa；José Realino de Paula

关键词

Benzodiazepine site ； GABA_A receptor ； Medicinal plants ； Molecular docking ； Pharmacophore model

期刊名称

Journal of Traditional and Complementary Medicine

卷期/出版年月

12卷4期（2022 / 07 / 01）

页次

318 - 329

内容语文

英文
中文摘要

Background and aim: Hibalactone (HB) is a lignan related to the anxiolytic-like effects of Hydrocotyle umbellata L. However, there is a need to understand better the mechanism of action of this lignan to support the ethnopharmacological uses of the species. This work aimed to evaluate by in vivo and in silico analysis the mechanism of action of HB involved in its anxiolytic-like effects. Experimental procedure: The effects of HB in mice were evaluated on light-dark box (LDB) and elevated plus maze (EPM) tests. The participation of 5-HT_(1A) receptor and the benzodiazepine site of GABA_A receptor was evaluated to investigate the possible mechanism of action. In silico tools were used to better elucidate the anxiolytic-like effects of HB. Results: Oral treatment with HB at a dose of 33 mg/kg showed an anxiolytic-like effect in the LDB and EPM tests. Besides that, the treatment altered the ethological parameters, frequency of head dips, and stretched-attend postures (SAP), important to better describe the anxiolytic profile of HB. Pretreatment with flumazenil (2 mg/kg) reverted the anxiolytic-like effect of HB on LDB and EPM tests. On the other hand, pretreatment with NAN-190 (0.5 mg/kg) not reverted the activity observed. In silico predictions revealed the potential of HB to increase GABAergic neurotransmission. Pharmacophore modelling and docking simulations showed that HB might interact with the α1β2γ2 GABA_A receptor. Conclusion: Together, the results presented herein suggest that activation of the benzodiazepine site of the GABA_A receptor contributes to the anxiolytic-like effect of HB.
主题分类 醫藥衛生 > 中醫藥學
参考文献
  1. Apers, S,Vlietinck, A,Pieters, L(2003).Lignans and neolignans as lead compounds.Phytochemistry Rev,2(3),201-217.
  2. Appel, K,Rose, T,Fiebich, B,Kammler, T,Hoffmann, C,Weiss, G(2010).Modulation of the γ-aminobutric acid (GABA) system by Passiflora incarnata L.Phytother Res,6,838-843.
  3. Awad, R,Muhammad, A,Durst, T,Trudeau, VL,Arnason, JT(2009).Bioassay-guided fractionation of lemon balm (Melissa officinalis L.) using an in vitro measure of GABA transaminase activity.Phytother Res,8,1075-1081.
  4. Babaev, O,Chatain, CP,Krueger-Burg, D(2018).Inhibition in the amygdala anxiety circuitry.Exp Mol Med,50(4),18.
  5. Bourin, M,Hascoët, M(2003).The mouse light-dark box test.Eur J Pharmacol,463(1-3),55-65.
  6. Carhart-Harris, RL,Nutt, DJ(2017).Serotonin and brain function: a tale of two receptors.J Psychopharmacol,31(9),1091-1120.
  7. Craske, MG,Stein, MB,Eley, TC(2017).Anxiety disorders.Nat Rev Dis Primers,3,17024.
  8. Crawley, JN,Goodwin, FK(1980).Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines.Pharmacol Biochem Behav,13,167-170.
  9. Daina, A,Michielin, O,Zoete, V(2019).SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules.Nucleic Acids Res,47,W357-W364.
  10. De Brito, AF,Martins, JL,Fajemiroye, JO(2012).Central pharmacological activity of a new piperazine derivative: 4-(1-phenyl-1H-pyrazol-4-ylmethyl)-piperazine-1-carboxylic acid ethyl ester.Life Sci,90(23-24),910-916.
  11. De Oliveira, MG,De Almeida, PH,Oliveira, TL(2019).HPLC-PDA method validated for the determination of hibalactone in Hydrocotyle umbellata subterraneous parts and its ultrasound-assisted extraction optimization.Rev Bras de Farm,29,162-170.
  12. Dos Santos, KB,Guedes, IA,Karl, ALM,Dardenne, LE(2020).Highly flexible ligand docking: benchmarking of the DockThor program on the LEADS-PEP protein-peptide dataset.J Chem Inf Model,60(2),667-683.
  13. Ennaceur, A,Chazot, PL(2016).Preclinical animal anxiety research - flaws and prejudices.Pharmacol Res,4,e00223.
  14. Ficher, DCH,Kato, ETM,Oliveira, F(1994).Estudo farmacognó de Hydrocotyle bonariensis Lam., adulterante de Centella asiatica (L.).Urban Lecta Rev Farm Biol,12,71-102.
  15. Gilhotra, N,Dhingra, D(2010).Neurochemical modulation of anxiety disorders.Int J Pharm Pharmaceut Sci,2(1),1-6.
  16. Gohlke, H,Hendlich, M,Klebe, G(2000).Knowledge-based scoring function to predict protein-ligand interactions.J Mol Biol,14(2),337-356.
  17. Gong, X,Shao, Y,Li, B,Chen, L,Wang, C,Chen, Y(2015).γ-Aminobutyric acid transporter-1 is involved in anxiety-like behaviors and cognitive function in knockout mice.Exp Ther Med,2,653-658.
  18. Griebel, G,Holmes, A(2013).50 years of hurdles and hope in anxiolytic drug discovery.Nat Rev Drug Discov,12(9),667-687.
  19. Griffin, CE, 3rd,Kaye, AM,Bueno, FR,Kaye, AD(2013).Benzodiazepine pharmacology and central nervous system-mediated effects.Ochsner J,13(2),214-223.
  20. Hintermann, S,Hurth, K,Nozulak, J(2011).Exploring subtype selectivity and metabolic stability of a novel series of ligands for the benzodiazepine binding site of the GABAA receptor.Bioorg Med Chem Lett,21(5),1523-1526.
  21. Huang, X,Liu, T,Gu, J(2001).3D-QSAR model of flavonoids binding at benzodiazepine site in GABAA receptors.J Med Chem,44(12),1883-1891.
  22. Khan, T,Lawrence, AJ,Azad, I,Raza, S,Joshi, S,Khan, AR(2019).Computational drug designing and prediction of important parameters using in silico methods - a review.Curr Comput-Aid Drug,15(5),384-397.
  23. Kim, S,Thiessen, PA,Bolton, EE(2016).PubChem substance and compound databases.Nucleic Acids Res,44,D1202-D1213.
  24. Komada, M,Takao, K,Miyakawa, T(2008).Elevated plus maze for mice.J Vis Exp,22,e1088.
  25. Kumar, V(2006).Potential medicinal plants for CNS disorders: an overview.Phytother Res,20,1023-1035.
  26. Lader, M(2011).Benzodiazepines revisited - will we ever learn?.Addiction,106(12),2086-2109.
  27. Lagunin, A,Ivanov, S,Rudik, A,Filimonov, D,Poroikov, V(2013).DIGEP-Pred: web service for in silico prediction of drug-induced gene expression profiles based on structural formula.Bioinformatics,29(16),2062-2063.
  28. Lagunin, A,Stepanchikova, A,Filimonov, D,Poroikov, V(2000).PASS: prediction of activity spectra for biologically active substances.Bioinformatics,16(8),747-748.
  29. Larsen, JS,Ahring, PK,Nielsen, EØ,Mirza, N(2013).Larsen JS, Ahring PK, Nielsen EØ, Mirza N. Benzimidazole Derivatives and Their Use for Modulating the GABAA Receptor Complex. 2013:US8492408..
  30. Lee, H,Le, HV,Wu, R(2015).Mechanism of inactivation of GABA aminotransferase by (E)- and (Z)-(1S,3S)-3-Amino-4-fluoromethylenyl-1-cyclopentanoic acid.ACS Chem Biol,10(9),2087-2098.
  31. Lister, RG(1987).The use of a plus maze to measure anxiety in the mouse.Psychopharmacology,92,180-185.
  32. Liu, T,Lin, Y,Wen, X,Jorissen, RN,Gilson, MK(2007).BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities.Nucleic Acids Res,35,D198-D201.
  33. Lorenz-Guertin, JM,Jacob, TC(2018).GABA type a receptor trafficking and the architecture of synaptic inhibition.Dev Neurobiol,78(3),238-270.
  34. Lundstrom, K,Pham, HT,Dinh, LD(2017).Interaction of plant extracts with central nervous system receptors.Medicines,4(1),12.
  35. Martin, EI,Ressler, KJ,Binder, E,Nemeroff, CB(2009).The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology.Psychiatr Clin,32(3),549-575.
  36. Moreira, LK,De Brito, AF,Fontana, C(2020).Neuropharmacological assessment in mice and molecular docking of piperazine derivative LQFM212.Behav Brain Res,394,112827.
  37. Nantasenamat, C,Isarankura-Na-Ayudhya, C,Prachayasittikul, V(2010).Advances in computational methods to predict the biological activity of compounds.Expet Opin Drug Discov,5(7),633-654.
  38. Nuss, P(2015).Anxiety disorders and GABA neurotransmission: a disturbance of modulation.Neuropsychiatric Dis Treat,11,165-175.
  39. Nuss, P(2015).Anxiety disorders and GABA neurotransmission: a disturbance of modulation.Neuropsychiatric Dis Treat,11,165-175.
  40. Oliveira, TLS,Morais, SR,Sá, S(2017).Antinociceptive, anti-inflammatory and anxiolytic-like effects of the ethanolic extract, fractions and hibalactone isolated from Hydrocotyle umbellata L. (Acariçoba) - Araliaceae.Biomed Pharmacother,95,837-846.
  41. Olivier, A,Sevrin, M,Durant, F(1997).A conformational study of ligands for omega modulatory sites of GABAA receptors by NOESY NMR spectroscopy and distance geometry.Bioorg Med Chem Lett,7(17),2277-2282.
  42. Olivier, JDA,Vinkers, CH,Olivier, B(2013).The role of the serotonergic and GABA system in translational approaches in drug discovery for anxiety disorders.Front Pharmacol,4,74.
  43. Ramos, A(2008).Animal models of anxiety: do I need multiple tests?.Trends Pharmacol Sci,29(10),493-498.
  44. Scaglione, F,Zangara, A(2017).Valeriana officinalis and Melissa officinalis extracts normalize brain levels of GABA and glutamate altered by chronic stress.J Sleep Disord Manag,3,16.
  45. Schneidman-Duhovny, D,Dror, O,Inbar, Y,Nussinov, R,Wolfson, HJ(2008).PharmaGist: a webserver for ligand-based pharmacophore detection.Nucleic Acids Res,36,W223-W228.
  46. Sharma, A,Cardoso-Taketa, A,Garcia, G,Villarreal, ML(2012).A systematic updated review of scientifically tested selected plants used for anxiety disorders.Botanics Targets Ther,2,21-39.
  47. Shepherd, JK,Grewal, SS,Fletcher, A,Bill, DJ,Dourish, CT(1994).Behavioural and pharmacological characterization of the elevated "zero-maze" as an animal model of anxiety.Psychopharmacology,116,56-64.
  48. Strawn, JR,Geracioti, L,Rajdev, N,Clemenza, K,Levine, A(2018).Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review.Expet Opin Pharmacother,19(10),1057-1070.
  49. Takaku, N,Choi, DH,Mikame, K(2001).Lignans of Chamaecyparis obtuse.J Wood Sci,47,476-482.
  50. Wu, C,Sun, D(2015).GABA receptors in brain development, function, and injury.Metab Brain Dis,30(2),367-379.
  51. Yin, L,Zheng, L,Xu, L(2015).In-silico prediction of drug targets, biological activities, signal pathways and regulating networks of dioscin based on bioinformatics.BMC Compl Alternative Med,15,41.
  52. Zhu, S,Noviello, CM,Teng, J,Walsh, RM, Jr,Kim, JJ,Hibbs, RE(2018).Structure of a human synaptic GABAA receptor.Nature,559,67-72.
  53. Zhu, S,Noviello, CM,Teng, J,Walsh, RM,Kim, JJ,Hibbs, RE(2018).Structure of a humansynaptic GABAA receptor.Nature,559,67-72.
print cancel